(Q36080357)

12 August 2017

Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer (English)

1 reference

12 August 2017

1 reference

1 reference

1 reference

1 reference

Ellis PA

1

1 reference

12 August 2017

Smith IE

2

1 reference

12 August 2017

Hardy JR

3

1 reference

12 August 2017

Nicolson MC

4

1 reference

12 August 2017

Talbot DC

5

1 reference

12 August 2017

Ashley SE

6

1 reference

12 August 2017

Priest K

7

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 February 1995

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

71

1 reference

12 August 2017

2

1 reference

12 August 2017

366-370

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1995.74

12 August 2017

0 references

cites work

Reporting results of cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033578

Cisplatin and vindesine combination chemotherapy for non-small cell lung cancer: a randomized trial comparing two dosages of cisplatin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033578

Patterns of mediastinal metastases in bronchogenic carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033578

Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compare

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033578

Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033578

Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033578

A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033578

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033578

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033578

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033578

Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033578

Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033578

Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer

23 September 2018

1 reference

12 December 2020

Polychemotherapy in advanced non small cell lung cancer: a meta-analysis

1 reference

12 December 2020

Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules

1 reference

12 December 2020

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer

1 reference

12 December 2020

A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma

1 reference

12 December 2020

Chemotherapy of Advanced Non-Small-Cell Lung Cancer with Cyclophosphamide, Adriamycin, Methotrexate, and Procarbazine versus Cisplatin and Etoposide A Randomized Study

1 reference

12 December 2020

Randomized comparison of two combination regimens versus minimal chemotherapy in nonsmall-cell lung cancer: a Southeastern Cancer Study Group Trial

1 reference

12 December 2020

Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer

1 reference

12 December 2020

Symptomatic treatmentversus combination chemotherapy for patients with extensive non-small cell lung cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1995.74

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference

12 August 2017

1 reference